These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17034142

  • 1. Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.
    Moyle PM, Olive C, Ho MF, Good MF, Toth I.
    J Med Chem; 2006 Oct 19; 49(21):6364-70. PubMed ID: 17034142
    [Abstract] [Full Text] [Related]

  • 2. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM, Olive C, Good MF, Toth I.
    J Pept Sci; 2006 Dec 19; 12(12):800-7. PubMed ID: 17131293
    [Abstract] [Full Text] [Related]

  • 3. Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.
    Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Batzloff MR, Olive C, Good MF, Toth I.
    J Med Chem; 2008 Mar 13; 51(5):1447-52. PubMed ID: 18278857
    [Abstract] [Full Text] [Related]

  • 4. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
    Olive C, Hsien K, Horváth A, Clair T, Yarwood P, Toth I, Good MF.
    Vaccine; 2005 Mar 18; 23(17-18):2298-303. PubMed ID: 15755615
    [Abstract] [Full Text] [Related]

  • 5. Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.
    Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I.
    J Med Chem; 2004 Jul 29; 47(16):4100-4. PubMed ID: 15267249
    [Abstract] [Full Text] [Related]

  • 6. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C, Sun HK, Ho MF, Dyer J, Horváth A, Toth I, Good MF.
    J Infect Dis; 2006 Aug 01; 194(3):316-24. PubMed ID: 16826479
    [Abstract] [Full Text] [Related]

  • 7. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF.
    J Infect Dis; 2006 Jun 15; 193(12):1666-76. PubMed ID: 16703510
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.
    Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I.
    J Med Chem; 2008 Jan 10; 51(1):167-72. PubMed ID: 18072728
    [Abstract] [Full Text] [Related]

  • 9. Lipid core peptide technology and group A streptococcal vaccine delivery.
    Olive C, Batzloff MR, Toth I.
    Expert Rev Vaccines; 2004 Feb 10; 3(1):43-58. PubMed ID: 14761243
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.
    Zaman M, Abdel-Aal AB, Fujita Y, Ziora ZM, Batzloff MR, Good MF, Toth I.
    J Med Chem; 2012 Oct 11; 55(19):8515-23. PubMed ID: 22974133
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.
    Simerska P, Abdel-Aal AB, Fujita Y, Batzloff MR, Good MF, Toth I.
    Biopolymers; 2008 Oct 11; 90(5):611-6. PubMed ID: 18381625
    [Abstract] [Full Text] [Related]

  • 12. Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.
    Moyle PM, Olive C, Ho MF, Burgess M, Karpati L, Good MF, Toth I.
    J Org Chem; 2006 Sep 01; 71(18):6846-50. PubMed ID: 16930036
    [Abstract] [Full Text] [Related]

  • 13. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
    Batzloff MR, Hartas J, Zeng W, Jackson DC, Good MF.
    J Infect Dis; 2006 Aug 01; 194(3):325-30. PubMed ID: 16826480
    [Abstract] [Full Text] [Related]

  • 14. Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.
    Olive C, Moyle PM, Toth I.
    Curr Med Chem; 2007 Aug 01; 14(28):2976-88. PubMed ID: 18220734
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of a Streptococcus pyogenes vaccine candidate based on the M protein PL1 epitope.
    Simerska P, Lu H, Toth I.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):821-4. PubMed ID: 19097790
    [Abstract] [Full Text] [Related]

  • 16. Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.
    Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF.
    Infect Immun; 2003 May 01; 71(5):2373-83. PubMed ID: 12704107
    [Abstract] [Full Text] [Related]

  • 17. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P, Jones KF, Geller BL.
    Infect Immun; 2004 Jun 01; 72(6):3444-50. PubMed ID: 15155651
    [Abstract] [Full Text] [Related]

  • 18. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.
    Hayman WA, Toth I, Flinn N, Scanlon M, Good MF.
    Immunol Cell Biol; 2002 Apr 01; 80(2):178-87. PubMed ID: 11940119
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.
    Fujita Y, Abdel-Aal AB, Wimmer N, Batzloff MR, Good MF, Toth I.
    Bioorg Med Chem; 2008 Oct 01; 16(19):8907-13. PubMed ID: 18789866
    [Abstract] [Full Text] [Related]

  • 20. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP, Wibowo N, Connors NK, Wu Y, Hughes FK, Batzloff MR, Lua LH, Middelberg AP.
    Biotechnol Bioeng; 2014 Jun 01; 111(6):1062-70. PubMed ID: 24338691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.